These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2391544)

  • 1. Myoglobin is a sensitive marker of increased muscle membrane vulnerability.
    Driessen-Kletter MF; Amelink GJ; Bär PR; van Gijn J
    J Neurol; 1990 Jul; 237(4):234-8. PubMed ID: 2391544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of serum myoglobin in neuromuscular diseases and in carrier detection of Duchenne muscular dystrophy.
    Nørregaard-Hansen K; Hein-Sørensen O
    Acta Neurol Scand; 1982 Aug; 66(2):259-66. PubMed ID: 7136489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoglobin RIA in detecting carriers of Duchenne's muscular dystrophy.
    Sabria-Leal M; Gimeno-Leal JM; Paret-Masana A; Rey-Joly Barroso C
    Eur Neurol; 1986; 25(4):253-5. PubMed ID: 3720800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term immobilization after eccentric exercise. Part II: creatine kinase and myoglobin.
    Sayers SP; Clarkson PM
    Med Sci Sports Exerc; 2003 May; 35(5):762-8. PubMed ID: 12750585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and identification of myoglobin in serum by immunoblotting. Effect of exercise on patients with Duchenne muscular dystrophy.
    Pöche H; Hopfenmüller W; Hoffmann M
    Clin Physiol Biochem; 1987; 5(2):103-11. PubMed ID: 3304774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle enzymes and isoenzymes in Emery-Dreifuss muscular dystrophy.
    Bialer MG; Bruns DE; Kelly TE
    Clin Chem; 1990 Mar; 36(3):427-30. PubMed ID: 2311208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of simultaneous estimation of serum creatine kinase and myoglobin in neuromuscular diseases.
    Diószeghy P; Mechler F
    J Neurol; 1988 Jan; 235(3):174-6. PubMed ID: 3367167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?
    Florence JM; Fox PT; Planer GJ; Brooke MH
    Neurology; 1985 May; 35(5):758-61. PubMed ID: 4039424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary progressive muscular dystrophies: serum myoglobin pattern in patients with different types of muscular dystrophies.
    Pöche H; Kattner E; Beckmann R; Pernice W; Schneider V
    Clin Physiol Biochem; 1989; 7(1):40-6. PubMed ID: 2752671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison analysis of muscle enzymes in children with myocarditis and Duchene/Becker muscular dystrophy].
    Zhang Y; Wang H; Yu X; Xing Y; Wang C; He R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):984-91. PubMed ID: 27640799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of myoglobin and creatine kinase in Duchenne muscular dystrophy.
    Kiessling WR; Beckmann R
    Klin Wochenschr; 1981 Apr; 59(7):347-8. PubMed ID: 7241957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fluctuation of serum myoglobin levels in Duchenne muscular dystrophy and the carrier.
    Konagaya M; Takayanagi T; Konagaya Y; Sobue I
    J Neurol Sci; 1982 Sep; 55(3):259-65. PubMed ID: 6890096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
    Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
    Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases.
    Mokuno K; Riku S; Matsuoka Y; Sobue I; Kato K
    J Neurol Sci; 1984 Mar; 63(3):345-52. PubMed ID: 6726277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle and serum enzymes and isoenzymes in muscular dystrophies.
    Ibrahim GA; Zweber BA; Awad EA
    Arch Phys Med Rehabil; 1981 Jun; 62(6):265-9. PubMed ID: 7235920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of plasma myoglobin levels in the adult and fetus at-risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    J Neurol Sci; 1984 Feb; 63(2):173-82. PubMed ID: 6707690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.